Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Vascular contributions

Topic: Brain proteins, microglia and lab models

Abstract Background Optical coherence tomography angiography (OCTA) is a quick, noninvasive modality that visualizes retinal microvasculature. The retina is known to be the mirror of the brain, thus it is pertinent to employ OCTA to study covert cerebral small vessel disease (CSVD). Methods This is an observational case–control study of 40 patients with CSVD and 20 healthy controls. Mini-mental state examination (MMSE) was performed for all subjects, to exclude dementia. Fazekas grading and SVD score were determined by MRI. OCTA was performed for both groups and included various parameters of superficial and deep retinal capillary plexus density, macular, foveal and ganglion cell complex thickness, in addition to optic nerve head scans. Results Seventy percent of the patients had a low SVD score (1). Case group had significantly lower scores on most parameters of retinal capillary plexus density and macular thickness p < 0.05. Impairment of OCTA parameters was associated with higher Fazekas and SVD scores. Conclusion OCTA is a handy, noninvasive tool that enables the visualization of diminished retinal microvascular density in cases of early CSVD. It can serve as a screening tool for identifying vulnerable populations, facilitating early management for CSVD.

Key findings

Why it matters

In this small case-control study of 40 patients with cerebral small vessel disease and 20 controls, patients had significantly lower retinal capillary plexus density and macular thickness, and these impairments were associated with higher Fazekas and SVD scores. The authors suggest OCTA could serve as a screening tool for early small vessel disease, but it is a small observational study and not a treatment.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 32 of 100.32 of 100 points earned68 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (The Egyptian Journal of Neurology Psychiatry and Neurosurgery)
Journal's citation record 0 / 4 The Egyptian Journal of Neurology Psychiatry and Neurosurgery: journal h-index 35 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 40 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Hossam Shokri: h-index 11 (OpenAlex, whole career)
Institution's track record 0 / 3 Ain Shams University: institution h-index 314 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

El Nahas, N. M., Roushdy, T. M. E. S., El Din, M. M. W., Abdellatif, M. E. A., Gaber, S., Ebeid, W. M., et al. (2025). Retinal vessel density using optical coherence tomography angiography as a potential biomarker in patients with cerebral small vessel disease. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. https://doi.org/10.1186/s41983-025-00973-6

Vancouver

El Nahas NM, Roushdy TMES, El Din MMW, Abdellatif MEA, Gaber S, Ebeid WM, et al. Retinal vessel density using optical coherence tomography angiography as a potential biomarker in patients with cerebral small vessel disease. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 2025. doi:10.1186/s41983-025-00973-6.

BibTeX

@article{elnahas2025-09badbf7,
  author  = {El Nahas, Nevine M. and Roushdy, Tamer Mahmoud El Sayed and El Din, Mona Mokhtar Wahid and Abdellatif, Mona Elsayed Ahmed and Gaber, Sara and Ebeid, Weam Mohamed and Shokri, Hossam},
  title   = {{Retinal vessel density using optical coherence tomography angiography as a potential biomarker in patients with cerebral small vessel disease}},
  journal = {The Egyptian Journal of Neurology Psychiatry and Neurosurgery},
  year    = {2025},
  doi     = {10.1186/s41983-025-00973-6},
  url     = {https://doi.org/10.1186/s41983-025-00973-6}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Vascular contributions

Similar studies

More on Vascular contributions

See all studies in Vascular contributions →